Journal
CELL STEM CELL
Volume 13, Issue 4, Pages 382-384Publisher
CELL PRESS
DOI: 10.1016/j.stem.2013.08.003
Keywords
-
Categories
Funding
- Medical Research Council [G0700711B] Funding Source: researchfish
Ask authors/readers for more resources
The ability to preselect the donor genotype of iPSC lines provides important opportunities for immunematching in cell therapy. Here we propose that an international assessment should be made of how immune incompatibility can best be managed and how a network of GMP HLA homozygous haplobanks could be operated.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available